Intellipharmaceutics International Inc.

Intellipharmaceutics technologies are a multidimensional controlled-release drug delivery platform that we believe can be applied to the efficient development of a wide range of existing and new pharmaceuticals.At Intellipharmaceutics, we are engaged in the research, development and commercialization of controlled-release and targeted pharmaceutical products, both novel and generic, with a particular emphasis in the opioid abuse deterrence space.

Bank Name Intellipharmaceutics International Inc.
Stock Exchange NASDAQ
Symbol IPCI
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region Amarica
Chairman Dr. Isa Odidi
CEO Dr. Isa Odidi
Employees
Website www.intellipharmaceutics.com
Registered Year 1998

UpdateContent
UpdateContent
UpdateContent